TB-500 vs IGF-1 LR3 at a glance
| TB-500 | IGF-1 LR3 | |
|---|---|---|
| Also known as | Thymosin Beta-4 fragment | Long R3 Insulin-like Growth Factor 1 |
| Category | Healing & Recovery | Growth Hormone & Muscle |
| Format | SubQ / IM | SubQ / IM |
| Research level | Beginner | Advanced |
| Research sizes | 5 mg vial, 10 mg vial | 1 mg vial |
| In one line | A synthetic version of the active region of Thymosin Beta-4, studied for deep-tissue regeneration. | A long-acting IGF-1 analog studied as one of the most anabolic research peptides. |
What is TB-500?
TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.
TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.
What is IGF-1 LR3?
IGF-1 LR3 is a modified, long-acting analog of insulin-like growth factor 1, with an 83-amino-acid structure and a reduced affinity for binding proteins that gives it an extended active half-life in research models.
IGF-1 LR3 research focuses on IGF-1-receptor activation driving cell proliferation, nutrient partitioning, and anabolic signaling. Its extended half-life is the defining research feature versus native IGF-1.
Key research differences
The two are best understood by what each is studied for. TB-500: Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest. IGF-1 LR3: Where GHRPs and GHRH analogs stimulate endogenous GH, IGF-1 LR3 supplies a downstream IGF signal directly, making it a distinct and more advanced research tool.
How researchers choose between them
TB-500 and IGF-1 LR3 belong to different research categories (Healing & Recovery versus Growth Hormone & Muscle), so they are usually chosen for different research questions rather than as direct substitutes. Some protocols study them together to cover complementary endpoints. Whichever you select, compare on verified quality: both are third-party tested to a 99%+ purity target with a COA on request.
Frequently asked questions
What is the difference between TB-500 and IGF-1 LR3?
TB-500 a synthetic version of the active region of Thymosin Beta-4, studied for deep-tissue regeneration; IGF-1 LR3 a long-acting IGF-1 analog studied as one of the most anabolic research peptides. They belong to different research categories (Healing & Recovery vs Growth Hormone & Muscle). Both are research-use-only.
Can TB-500 and IGF-1 LR3 be studied together?
In some research designs, yes - they cover different endpoints, so a protocol may include both. Any combination work is laboratory research only.
Which is better, TB-500 or IGF-1 LR3?
Neither is universally "better" - the right choice depends on the research question. Match the compound to your model's target signal, and compare suppliers on verifiable third-party purity, not sticker price.
All comparisons · TB-500 · IGF-1 LR3 · TB-500 cost
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration